Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05704985 · ClinicalTrials.gov registry record · Phase 1
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
A Phase 1 study of Cancer and Non-Small Cell Lung Cancer, sponsored by DEKA Biosciences.
- Active
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
- 7
- Study locations
NCT05704985 is a Phase 1 study of Cancer and Non-Small Cell Lung Cancer that is active but no longer recruiting, run by DEKA Biosciences. The registered enrollment target is 39 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT05704985, a Phase 1 study of Cancer and Non-Small Cell Lung Cancer, is active but no longer recruiting, sponsored by DEKA Biosciences.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study will evaluate safety, pharmacodynamics and biomarkers of subcutaneous (SC) DK210(EGFR) given as monotherapy and in combination with immunotherapy, chemotherapy or radiation.
Conditions Studied
Interventions
- DRUG Chemotherapy
- RADIATION Radiation therapy
- BIOLOGICAL DK210 (EGFR)
- BIOLOGICAL Immune checkpoint blockers
Study Locations (7)
Texas
- Mary Crowley Cancer Research - Dallas
- University of Texas Southwestern - Dallas
- The University of Texas M.D. Anderson Cancer Center - Houston
California
- City of Hope - Duarte
New York
- Northwell Health - Manhasset
Oklahoma
- OU Health Stephenson Cancer Center - Oklahoma City
Virginia
- NEXT Oncology - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2025-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05704985
The ClinicalTrials.gov registry entry for NCT05704985 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is DEKA Biosciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Chemotherapy is the first listed.
NCT05704985 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Texas, California, New York.
Frequently Asked Questions
What is clinical trial NCT05704985 about?
NCT05704985 is a clinical study titled "Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors". This study will evaluate safety, pharmacodynamics and biomarkers of subcutaneous (SC) DK210(EGFR) given as monotherapy and in combination with immunotherapy, chemotherapy or radiation.
What is the current status of trial NCT05704985?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2023-04-03. Estimated completion is 2025-10.
What conditions does trial NCT05704985 study?
This clinical trial studies the following conditions: Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Head and Neck Cancer, Solid Tumor.
What interventions are being tested in trial NCT05704985?
The interventions under investigation include: Chemotherapy (DRUG), Radiation therapy (RADIATION), DK210 (EGFR) (BIOLOGICAL), Immune checkpoint blockers (BIOLOGICAL).
Who is sponsoring clinical trial NCT05704985?
This trial is sponsored by DEKA Biosciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05704985 being conducted?
This trial has 7 study locations across California, New York, Oklahoma, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Impact of Daily Oral Cannabis Doses in Patients With Cancer
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.